Jonsson Comprehensive Cancer Center
🇺🇸United States
Gemtuzumab in Treating Patients With Myelodysplastic Syndrome
Phase 2
- Conditions
- First Posted Date
- 2004-01-14
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00022321
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-01-08
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 8
- Registration Number
- NCT00020787
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Temozolomide in Treating Patients With Solid Tumors That Have Spread to the Brain
- First Posted Date
- 2004-01-01
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 4
- Registration Number
- NCT00012116
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
Phase 2
Withdrawn
- Conditions
- First Posted Date
- 2003-12-16
- Last Posted Date
- 2012-10-04
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00005083
Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1
Completed
- Conditions
- First Posted Date
- 2003-12-02
- Last Posted Date
- 2009-02-09
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00003409
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸University of California Davis Cancer Center, Sacramento, California, United States
Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00072072
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00072059
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-11-06
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 15
- Registration Number
- NCT00071968
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States
INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer
Not Applicable
- Conditions
- First Posted Date
- 2003-10-22
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT00033527
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
- First Posted Date
- 2003-10-07
- Last Posted Date
- 2020-08-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 14
- Registration Number
- NCT00070382
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
© Copyright 2024. All Rights Reserved by MedPath